{"paper_id":"af735efd-d850-403b-8167-839b6fd44c71","body_text":"The role of mutations in the PI3K/AKT/mTOR- signal pathway in decreasing ovarian reserve in reproductive patients with deep infiltrative endometriosis\n- Authors: Melkozerova O.A1, Okulova E.O1, Mikhelson A.A1, Tretyakova T.B1\n-\nAffiliations:\n- Ural Scientific Research Institute of Maternity and Child Care\n- Issue: Vol 16, No 2 (2021)\n- Pages: 66-70\n- Section: Articles\n- Submitted: 16.01.2023\n- Published: 15.06.2021\n- URL: https://genescells.ru/2313-1829/article/view/121918\n- DOI: https://doi.org/10.23868/202107008\n- ID: 121918\nCite item\nAbstract\nFull Text\nAbout the authors\nO. A Melkozerova\nUral Scientific Research Institute of Maternity and Child Care\nE. O Okulova\nUral Scientific Research Institute of Maternity and Child Care\nA. A Mikhelson\nUral Scientific Research Institute of Maternity and Child Care\nT. B Tretyakova\nUral Scientific Research Institute of Maternity and Child Care\nReferences\n- Адамян Л.В., ред. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации. Москва; 2020.\n- Адамян Л.В., Салимова Д.Ф., Кондратович Л.М. Патогенетические аспекты эндометриоз-ассоциированного бесплодия. Проблемы репродукции 2015; 21(6): 90-6.\n- Башмакова Н.В., Мелкозерова О.А., Михельсон А.А. и др. Роль средовых факторов в патогенезе бесплодия, ассоциированного с генитальным эндометриозом (обзор литературы). Проблемы репродукции 2019; 25(5): 42-8.\n- Мелкозерова О.А., Башмакова Н.В., Окулова Е.О. Генетические и эпигенетические механизмы бесплодия, ассоциированного с генитальным эндометриозом. Акушерство и гинекология 2019; 8: 26-32.\n- Barnett R., Banks N., Decherney A.H. Endometriosis and Fertility Preservation. Clin. Obstet. Gynecol. 2017; 60(3): 517-23.\n- Hsueh A.J. Fertility: the role of mTOR signaling and KIT ligand. Curr. Biol. 2014; 24(21): R1040-2.\n- Ashrafi M., Arabipoor A., Hemat M. et al. The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes. J. Obstet. Gynecol. 2019; 39(1): 91-7.\n- Romanski P.A., Brady P.C., Farland L.V. et al. The effect of endometriosis on the antimullerian hormone level in the infertile population. J. Assist. Reprod. Genet. 2019; 36(6): 1179-84.\n- Kasapoglu I., Ata B., Uyaniklar O. et al. Endometrioma-related Reduction in Ovarian Reserve (ERROR): A Prospective Longitudinal Study. Fertil. Steril. 2018; 110(1): 122-7.\n- Garavaglia E., Sala C., Taccagni G. et al. Fertility Preservation in Endometriosis Patients: Anti-Mullerian Hormone Is a Reliable Marker of the Ovarian Follicle Density. Front. Surg. 2017; 4: 40.\n- Kawamura K., Cheng Y., Suzuki N. et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. PNAS USA 2013; 110(43): 17474-9.\n- Rehnitz J., Alcoba D.D., Brum I.S. et al. FMR1 and AKT/mTOR signalling pathways: potential functional interactions controlling folliculogenesis in human granulosa cells. Reprod. Biomed. Online 2017; 35(5): 485-93.\n- Takeuchi A., Koga K., Satake E. et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J. Clin. Endocrinol. Metab. 2019; 104(11): 5547-54.\n- Alqahtani A., Ayesh H.S.K., Halawani H. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis. Cancers (Basel) 2019; 12(1): 93.\n- Su Y.F., Tsai E.M., Chen C.C. et al. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma. Clin. Chim. Acta 2019; 494: 1-7.\n- Adashek J.J., Kato S., Lippman S.M. et al. The paradox of cancer genes in non-malignant conditions: implications for precision medicine. Genome Med. 2020; 12(1): 16.\n- Adewuyi E.O., Sapkota Y., Auta A. et al. Shared Molecular Genetic Mechanisms Underlie Endometriosis and Migraine Comorbidity. Genes (Basel) 2020; 11(3): 268.\n- Anglesio M.S., Papadopoulos N., Ayhan A. et al. Cancer-Associated Mutations in Endometriosis without Cancer. N. Engl. J. Med. 2017; 376(19): 1835-48.\n- Lac V., Verhoef L., Aguirre-Hernandez R. et al. Iatrogenic endometriosis harbors somatic cancer-driver mutations. Hum. Reprod. 2019; 34(1): 69-78.\n- Zou Y., Zhou J.Y., Guo J.B. et al. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis. Mutat. Res. 2018; 809: 1-5.\n- McKinnon B.D., Kocbek V., Nirgianakis K. et al. Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics. Hum. Reprod. Update 2016; 22(3): 382-403.\n- Takeuchi A., Koga K., Satake E. et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J. Clin. Endocrinol. Metab. 2019; 104: 5547-54.\n- Madanes D., Bilotas M.A., Baston J.I. et al. PI3K/AKT pathway is altered in the endometriosis patient's endometrium and presents differences according to severity stage. Gynecol. Endocrinol. 2020; 36(5): 436-40.\n- Bora G., Yaba A. The role of mitogen-activated protein kinase signaling pathway in endometriosis. J. Obstet. Gynecol. Res. 2021; 47(5): 1610-23.\n- Barra F., Ferro Desideri L., Ferrero S. Inhibition of PI3K/AKT/ mTOR pathway for the treatment of endometriosis. Br.J. Pharmacol. 2018; 175(17): 3626-7.\n- Kacan T., Yildiz C., Baloglu Kacan S. et al. Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study. Geburtshilfe Frauenheilkd 2017; 77(1): 66-72.","source_license":"CC0","license_restricted":false}